The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Inbrain Neuroelectronics’ neural platform for its potential to provide more effective deep brain stimulation (DBS) as an add-on Parkinson’s treatment. The platform
Measuring levels of an enzyme called DOPA decarboxylase (DDC) in the blood or fluid around the brain and spinal cord may help distinguish Parkinson’s disease and related disorders from non-Parkinsonian neurodegenerative diseases, a study reports.
When the alpha-synuclein protein is present at high concentrations around cellular membranes, it lifts up rather than lying flat against the membrane, making it more prone to clumping, a study shows. The finding may offer
Michael J. Fox has received the 2023 Elevate Prize Catalyst Award in recognition of his work with the Michael J. Fox Foundation for Parkinson’s Research (MJFF), an organization dedicated to developing better treatments, and eventually,
Dopamine-making neurons — whose loss characterizes Parkinson’s disease — produce thousands of circular RNA molecules that, beyond their normal duties, may play a role in neurodegenerative diseases, a study reports. “Circular RNA has long been